Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T George

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Translational Psychiatry|July 2, 2024
Factors underlying the neurofunctional domains of the Addictions Neuroclinical Assessment assessed by a standardized neurocognitive batteryTommy Gunawan, Jeremy W Luk, Melanie L Schwandt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 21, 2014
The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine studyLaura E Kwako, Primavera A Spagnolo, Melanie L Schwandt, et al.
Alcoholism, Clinical and Experimental Research|January 13, 2015
Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patientsPrimavera A Spagnolo, Vijay A Ramchandani, Melanie L Schwandt, et al.
Alcoholism, Clinical and Experimental Research|September 8, 2011
The biometric measurement of alcohol consumptionLawrence D Snell, Vijay A Ramchandani, Laura Saba, et al.
Archives of General Psychiatry|October 6, 2010
Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine studyJohn C Umhau, Reza Momenan, Melanie L Schwandt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 8, 2014
FKBP5 moderates alcohol withdrawal severity: human genetic association and functional validation in knockout miceMing-Chyi Huang, Melanie L Schwandt, Julia A Chester, et al.
Science (New York, N.Y.)|February 16, 2008
Neurokinin 1 receptor antagonism as a possible therapy for alcoholismDavid T George, Jodi Gilman, Jacqueline Hersh, et al.
Journal of the American Chemical Society|December 17, 2024
Palladium Bisphosphine Monoxide Complexes: Synthesis, Scope, Mechanism, and Catalytic RelevanceShenghua Yang, Min Deng, Ryan A Daley, et al.
Journal of Neurosurgery|June 17, 2023
Safety and feasibility clinical trial of nucleus accumbens deep brain stimulation for treatment-refractory opioid use disorderAli R Rezai, James J Mahoney, Manish Ranjan, et al.
Alcohol (Fayetteville, N.Y.)|November 17, 2009
Stress-related neuropeptides and alcoholism: CRH, NPY, and beyondRoberto Ciccocioppo, Donald R Gehlert, Andrey Ryabinin, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Translational Psychiatry|July 2, 2024
Factors underlying the neurofunctional domains of the Addictions Neuroclinical Assessment assessed by a standardized neurocognitive batteryTommy Gunawan, Jeremy W Luk, Melanie L Schwandt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 21, 2014
The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine studyLaura E Kwako, Primavera A Spagnolo, Melanie L Schwandt, et al.
Alcoholism, Clinical and Experimental Research|January 13, 2015
Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patientsPrimavera A Spagnolo, Vijay A Ramchandani, Melanie L Schwandt, et al.
Alcoholism, Clinical and Experimental Research|September 8, 2011
The biometric measurement of alcohol consumptionLawrence D Snell, Vijay A Ramchandani, Laura Saba, et al.
Archives of General Psychiatry|October 6, 2010
Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine studyJohn C Umhau, Reza Momenan, Melanie L Schwandt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 8, 2014
FKBP5 moderates alcohol withdrawal severity: human genetic association and functional validation in knockout miceMing-Chyi Huang, Melanie L Schwandt, Julia A Chester, et al.
Science (New York, N.Y.)|February 16, 2008
Neurokinin 1 receptor antagonism as a possible therapy for alcoholismDavid T George, Jodi Gilman, Jacqueline Hersh, et al.
Journal of the American Chemical Society|December 17, 2024
Palladium Bisphosphine Monoxide Complexes: Synthesis, Scope, Mechanism, and Catalytic RelevanceShenghua Yang, Min Deng, Ryan A Daley, et al.
Journal of Neurosurgery|June 17, 2023
Safety and feasibility clinical trial of nucleus accumbens deep brain stimulation for treatment-refractory opioid use disorderAli R Rezai, James J Mahoney, Manish Ranjan, et al.
Alcohol (Fayetteville, N.Y.)|November 17, 2009
Stress-related neuropeptides and alcoholism: CRH, NPY, and beyondRoberto Ciccocioppo, Donald R Gehlert, Andrey Ryabinin, et al.
Pageof 5